Skip to main content
MRNA
NASDAQ Life Sciences

GSK Patent Suits Over Spikevax, mResvia Settled With No Payments Owed

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$258.37
Mkt Cap
$103.151B
52W Low
$22.28
52W High
$267.5
52W Position info
1060% above low
Off High info
3.4% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MRNA has more than doubled off its 52-week low of $22.28.

Summary

GSK and Moderna settled the patent suits covering Spikevax, mNEXSPIKE and mResvia in the US and Europe on October 28, and the cross-licenses in infectious disease carry no payment obligation either way. GSK asked a Delaware federal court on Friday to dismiss its infringement claims with prejudice, so they cannot be refiled. That removes an overhang on Moderna's COVID and RSV franchises without costing cash — a clean win for a company that already booked a $950 million litigation settlement in its year-to-date results. The remaining patent exposure is the separate Pfizer/BioNTech web of suits, including Moderna's own 2022 case against Pfizer, which this deal does not touch.

At the time of this announcement, MRNA was trading at $258.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $103.2B. The 52-week trading range was $22.28 to $267.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MRNA - Latest Insights

MRNA
Nov 12, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $247.31
Real-time Price: $199.30 info
Change: -$48.01 (-19%) info
Market Cap: $78.901B info
MRNA
Nov 07, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $256.92
Real-time Price: $199.30 info
Change: -$57.62 (-22%) info
Market Cap: $78.901B info
MRNA
Nov 06, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $255.50
Real-time Price: $199.30 info
Change: -$56.20 (-22%) info
Market Cap: $78.901B info
MRNA
Nov 06, 2026, 7:07 AM EST
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $265.00
Real-time Price: $199.30 info
Change: -$65.70 (-25%) info
Market Cap: $78.901B info
MRNA
Nov 06, 2026, 6:47 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $252.01
Real-time Price: $199.30 info
Change: -$52.71 (-21%) info
Market Cap: $78.901B info